Cargando…

Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement

BACKGROUND: Zika virus (ZIKV), an arbovirus capable of causing neurological abnormalities, is a recognised human pathogen, for which a vaccine is required. As ZIKV antibodies can mediate antibody-dependent enhancement (ADE) of dengue virus (DENV) infection, a ZIKV vaccine must not only protect again...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shukla, Rahul, Shanmugam, Rajgokul K., Ramasamy, Viswanathan, Arora, Upasana, Batra, Gaurav, Acklin, Joshua A., Krammer, Florian, Lim, Jean K., Swaminathan, Sathyamangalam, Khanna, Navin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186774/ https://www.ncbi.nlm.nih.gov/pubmed/32305868 http://dx.doi.org/10.1016/j.ebiom.2020.102738

Ejemplares similares

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
por: Shukla, Rahul, et al.
Publicado: (2020)

Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
por: Poddar, Ankur, et al.
Publicado: (2016)

Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
por: Rajpoot, Ravi Kant, et al.
Publicado: (2018)

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
por: Shukla, Rahul, et al.
Publicado: (2020)

Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
por: Arora, Upasana, et al.
Publicado: (2012)

Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
por: Shukla, Rahul, et al.
Publicado: (2018)

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
por: Ramasamy, Viswanathan, et al.
Publicado: (2018)

Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera
por: Batra, Gaurav, et al.
Publicado: (2011)

Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
por: Mani, Shailendra, et al.
Publicado: (2013)

Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
por: Tripathi, Lav, et al.
Publicado: (2015)

Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris
por: Kaushik, Neha, et al.
Publicado: (2016)

Escherichia coli–expressed near full length HIV-1 envelope glycoprotein is a highly sensitive and specific diagnostic antigen
por: Talha, Sheikh M, et al.
Publicado: (2012)

An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes
por: Khanam, Saima, et al.
Publicado: (2007)

Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice
por: Aggarwal, Charu, et al.
Publicado: (2023)

Adenovirus Delivered Short Hairpin RNA Targeting a Conserved Site in the 5′ Non-Translated Region Inhibits All Four Serotypes of Dengue Viruses
por: Korrapati, Anil Babu, et al.
Publicado: (2012)

Dengue-specific subviral nanoparticles: design, creation and characterization
por: Khetarpal, Niyati, et al.
Publicado: (2013)

Simultaneous detection of Human Immunodeficiency Virus 1 and Hepatitis B virus infections using a dual-label time-resolved fluorometric assay
por: Myyryläinen, Tiina, et al.
Publicado: (2010)

Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity
por: Shukla, Rahul, et al.
Publicado: (2023)

Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen
por: Gurramkonda, Chandrasekhar, et al.
Publicado: (2009)

Enhanced cell density cultivation and rapid expression-screening of recombinant Pichia pastoris clones in microscale
por: Kaushik, Neha, et al.
Publicado: (2020)

Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin
por: Gurramkonda, Chandrasekhar, et al.
Publicado: (2010)

Cocculus hirsutus-Derived Phytopharmaceutical Drug Has Potent Anti-dengue Activity
por: Shukla, Rahul, et al.
Publicado: (2021)

Multiple Salivary Proteins from Aedes aegypti Mosquito Bind to the Zika Virus Envelope Protein
por: Valenzuela-Leon, Paola Carolina, et al.
Publicado: (2022)

Zika virus tropism during early infection of the testicular interstitium and its role in viral pathogenesis in the testes
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2020)

Evaluating the Safety of West Nile Virus Immunity During Congenital Zika Virus Infection in Mice
por: Acklin, Joshua A., et al.
Publicado: (2021)

Envelope Protein Ubiquitination Drives Zika Virus Entry and Pathogenesis
por: Giraldo, Maria I., et al.
Publicado: (2020)

Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice
por: Liang, Huabin, et al.
Publicado: (2018)

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes
por: Sood, Ruchi, et al.
Publicado: (2015)

ZDHHC11 Suppresses Zika Virus Infections by Palmitoylating the Envelope Protein
por: Hu, Dingwen, et al.
Publicado: (2023)

A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
por: Li, Anzhong, et al.
Publicado: (2018)

Identification of Potential Lead Molecules for Zika Envelope Protein from In Silico Perspective
por: Chellasamy, Selvaa Kumar, et al.
Publicado: (2019)

In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers
por: Metz, Stefan W., et al.
Publicado: (2017)

USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination
por: Wang, Yingchong, et al.
Publicado: (2021)

LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination
por: Hu, Dingwen, et al.
Publicado: (2021)

Development and characterization of mouse monoclonal antibodies targeting to distinct epitopes of Zika virus envelope protein for specific detection of Zika virus
por: Li, Chia-Jung, et al.
Publicado: (2021)

A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture
por: Raut, Rajendra, et al.
Publicado: (2015)

Plant‐produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice
por: Yang, Ming, et al.
Publicado: (2017)

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice
por: Chen, Mei-Yu, et al.
Publicado: (2020)

Immunization with truncated envelope protein of Zika virus induces protective immune response in mice
por: Han, Jian-Feng, et al.
Publicado: (2017)

Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure
por: Yang, Chunpeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cfgmr6271ol1span81086flok3